Mr Mrs Miss Ms Dr Other

Dr
Amy
Dawson

Patent Attorney

Glasgow Office

Life sciences

Telephone. +44(0) 141 229 5800
Email. [email protected]
Vcard
Linkedin

Experience

Amy joined HGF Glasgow in May 2020 as part of the Life Sciences group.

She graduated from the University of Glasgow with a first-class MSci in Immunology with Work Placement. This included a 12-month placement at GlaxoSmithKline R&D. Amy completed a PhD in Cancer Studies from the University of Glasgow. Her research involved using single cell RNA sequencing technology and proteomics to investigate the interaction of leukaemic stem cells and immune cells in the cancer microenvironment. Amy has also completed a post graduate certificate in Intellectual Property from Bournemouth University.

Since joining HGF, she has experience with client management, IP landscaping, drafting and prosecution, including UK and European prosecution. In most recent years, Amy has experience in the cell and gene therapy field, with particular experience in programmable gene therapy technologies and synthetic promoters.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MSCI

MSci in Immunology

PHD

PhD in Cancer Sciences

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate Intellectual Property

Publications

NK Cell Therapy – an IP update

View publication online

New Practice at the EPO: Divisional Applications and Sequence Listings

View publication online

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

CSR

Amy is a member of the IP Inclusive Scotland Committee.

Related News

HGF receives exceptional results in IAM Patent 1000 rankings 2025

We are proud to announce that HGF has once again achieved outstanding recognition in the IAM Patent 1000 – The World’s Leading Patent Professionals 2025. With 29 of our attorneys …

Read article

Innovation in the Energy Industry - Do You Have Freedom to Operate?

The energy transition has brought unprecedented change to the energy sector. Whilst change can bring uncertainty and challenges, it also brings opportunities. Many companies have already seized on the opportunity …

Read article

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

  This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as …

Read article
Event - 3rd June 2025

Salzburg Seminar: Patents, trademarks, intellectual property rights – how startups can act strategically

Young companies make many important decisions during the start-up phase. One of the most important questions is: How do I deal strategically with innovations, ideas, and brand development? Those who …

Event details

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us